34 results
6-K
EX-99.1
AMYT
Amryt Pharma Plc
28 Jun 21
Current report (foreign)
9:16am
EXHIBIT 99.1
Publication of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices … being the “Transaction”), a circular (the “Circular”) containing notice of a general meeting to be held at the Company’s headquarters at 45 Mespil
6-K
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
Farmaceutici S.p.A., an Italian società per azioni.
The Company published a scheme circular regarding the Transaction on February 16, 2023 (the “Scheme … Circular”). The parties expect the closing of the Transaction to take place in mid-April 2023.
Announcement of Sanction of Scheme of Arrangement Press
424B3
AMYT
Amryt Pharma Plc
28 Jun 21
Prospectus supplement
9:18am
of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings … ”), a circular (the “Circular”) containing notice of a general meeting to be held at the Company’s headquarters at 45 Mespil Road, Dublin 4, Ireland at 2
424B3
AMYT
Amryt Pharma Plc
28 Jun 21
Prospectus supplement
9:17am
of Circular to Amryt Shareholders in relation to the acquisition of Chiasma, Inc., and posting of Annual Report and Notices of General Meetings … ”), a circular (the “Circular”) containing notice of a general meeting to be held at the Company’s headquarters at 45 Mespil Road, Dublin 4, Ireland at 2
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
under the caption “Risk Factors” and elsewhere in Amryt’s Securities and Exchange Commission (“SEC”) filings and reports, including the Scheme Circular … to the extent required by applicable law.
Important Additional Information and Where to Find It
This announcement is not a substitute for the Scheme Circular
6-K
EX-99.1
actd0f
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
6-K
EX-99.3
mgqei1ir nyu89j
31 Jan 22
Current report (foreign)
7:32am
424B3
dmf64to io5u
22 Nov 21
Prospectus supplement
7:38am
424B3
ung ornddq
22 Nov 21
Prospectus supplement
7:39am
6-K
EX-99.1
lt79 e50t
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.2
w2lt2ei
23 Aug 21
Options Granted to Non-Executive Directors
8:16am
6-K
EX-99.3
am252s4 5q51ty
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
425
z4chu vxmgfu
28 Jul 21
Business combination disclosure
4:56pm
424B3
7siuy h8g388nugg574t
2 Jun 21
Prospectus supplement
10:10am
424B3
ucuwg9q3v0fu0oacs
2 Jun 21
Prospectus supplement
10:09am
6-K
EX-99.1
fgk9w2xneax7
5 Aug 21
Appoints Raj Kannan and Dr. Roni Mamluk as Non-Executive Directors
5:17pm
425
knvze25u9s8srp
15 Jun 21
Business combination disclosure
4:28pm
424B3
2zjnet6kq5
23 Aug 21
Prospectus supplement
8:17am
424B3
zzhh1kx
23 Aug 21
Prospectus supplement
8:18am
6-K
EX-99.4
f1x9jv0kz
5 May 21
Agreement and Plan of Merger
5:19pm